VISION trial
Description: A randomized clinical trial evaluating lutetium-177–PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer.
Primary topic: Radiopharmaceutical Chemistry and Applications (38%)
OpenAlex ID: keywords/vision-trial
